INSULIN LISPRO Pharmacologic Class Indexing
- Class set ID
- 468701e8-1663-4bc0-afbc-7c216688eec4
- Version
- 2
- Effective date
- 20110223
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020 | A-S Medication Solutions | 20260413 | 3 |
| These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999 | Eli Lilly and Company | 20260113 | 54 |
| These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 | Eli Lilly and Company | 20260109 | 86 |
| These highlights do not include all the information needed to use LYUMJEV safely and effectively. See full prescribing information for LYUMJEV. LYUMJEV (insulin lispro-aabc) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2020 | Eli Lilly and Company | 20251230 | 11 |
| These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017 | REMEDYREPACK INC. | 20251001 | 3 |
| These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG ® (insulin lispro). | Eli Lilly and Company | 20250617 | 12 |
| These highlights do not include all the information needed to use ADMELOG safely and effectively. See full prescribing information for ADMELOG ® . ADMELOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 2017 | Sanofi-Aventis U.S. LLC | Sanofi-Aventis Deutschland GmbH | 20250604 | 14 |
| These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 | A-S Medication Solutions | 20250401 | 24 |
| These highlights do not include all the information needed to use HUMALOG MIX75/25 safely and effectively. See full prescribing information for HUMALOG MIX75/25. HUMALOG MIX75/25 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 1999 | Eli Lilly and Company | 20240806 | 53 |
| These highlights do not include all the information needed to use INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25 safely and effectively. See full prescribing information for INSULIN LISPRO PROTAMINE AND INSULIN LISPRO MIX75/25. INSULIN LISPRO PROTAMINE AND INSULIN LISPRO injectable suspension Mix75/25, for subcutaneous use Initial U.S. Approval: 1999 This product is HUMALOG ® Mix75/25™ (insulin lispro protamine and insulin lispro). | Eli Lilly and Company | 20240806 | 11 |
| These highlights do not include all the information needed to use INSULIN LISPRO safely and effectively. See full prescribing information for INSULIN LISPRO. INSULIN LISPRO injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 This product is HUMALOG® (insulin lispro). | A-S Medication Solutions | 20240531 | 7 |
| These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 | A-S Medication Solutions | 20240215 | 8 |
| These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. HUMALOG (insulin lispro) injection, for subcutaneous or intravenous use Initial U.S. Approval: 1996 | A-S Medication Solutions | 20240124 | 7 |
| These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996 | Dispensing Solutions, Inc. | PSS World Medical, Inc. | 20120927 | 2 |
| These highlights do not include all the information needed to use HUMALOG safely and effectively. See full prescribing information for HUMALOG. Humalog (insulin lispro injection, USP [rDNA origin]) for injection Initial U.S. Approval: 1996 | Physicians Total Care, Inc. | 20120522 | 3 |
| HUMALOG ® Mix75/25 TM 75% INSULIN LISPRO PROTAMINE SUSPENSION AND 25% INSULIN LISPRO INJECTION (rDNA ORIGIN) 100 UNITS PER ML (U-100) | Physicians Total Care, Inc. | 20111220 | 2 |